Genetic Study of Obstructive Azoospermia

Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05631509
Collaborator
(none)
300
1
54
5.6

Study Details

Study Description

Brief Summary

In 1% of men with infertility, obstructive azoospermia (OA) may occur in congenital absence of the vas (CAVD) or idiopathic obstructive azoospermia . Many studies have shown that the pathogenic genes of OA are CFTR and ADGRG2 genes, and the inheritance mode is autosomal recessive. Although the conventional assisted reproductive technology(PESA/TESA) can help these patients have children, male patients who carry mutations of the disease-causing genes (CFTR and ADGRG2) will also pass on their mutations to the next generation, which will increase the risk of male offspring infertility. Therefore, genetic detection of CFTR and ADGRG2 genes is very necessary for CAVD patients before assisted reproduction. Genetic diagnosis plays a key role in preventing the disease to the offspring.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Genetic Study of Obstructive Azoospermia
    Actual Study Start Date :
    Jul 1, 2021
    Anticipated Primary Completion Date :
    Dec 31, 2025
    Anticipated Study Completion Date :
    Dec 31, 2025

    Outcome Measures

    Primary Outcome Measures

    1. mutation rate [through study completion, an average of 3 year]

      the mutation rate of CFTR and ADGRG2

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • (1) No sperm was found after centrifugation for 15min for two or more semen tests, and the interval between two tests was at least 2 weeks.

    (2) Blood FSH is normal; (3) Hematostatin b is normal; (4) Chromosome karyotype is normal or polymorphic; (5) Y chromosome microdeletion did not show the deletion:(main locus); (6) Biochemical fructose of seminal plasma : less than the normal value; (7) PH of semen <7.2; (8) Transscrotal or transrectal ultrasound: normal testicular size(as measured by B ultrasound), presence or dysplasia of vas deferens and epididymis;

    Exclusion Criteria:
    • (1) B ultrasound of urinary system suggested abnormal development; (2) Transscrotal or Transrectal ultrasound indicated absence of vas deferens or epididymis or seminal vesicle; (3) Physical examination showed the following abnormalities: cryptorchidism, tenderness of testis and epididymis; (4) The following medical history: genitourinary tract trauma or surgical history; orchitis; epididymitis; Seminal vesicle disease; mumps; (5) Laboratory examination: red and white blood cell elevation of semen routine

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 107 Yan Jiang Xi Road Guangzhou Guangdong China 510080

    Sponsors and Collaborators

    • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    ClinicalTrials.gov Identifier:
    NCT05631509
    Other Study ID Numbers:
    • SYSEC-KY-KS-2021-116
    First Posted:
    Nov 30, 2022
    Last Update Posted:
    Nov 30, 2022
    Last Verified:
    Nov 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 30, 2022